Preclinical evaluation of Affibody molecule for PET imaging of human pancreatic islets derived from stem cells
ConclusionTargeting of DGCR2 is a promising approach for in vivo detection of stem-cell-derived islets grafts by molecular imaging. The synthesis of [18F]ZDGCR2:AM106 was successfully performed via a pretargeting method to label a site-specific covalently bonded fluorine-18 to the Affibody molecule. However, the rapid washout of [18F]ZDGCR2:AM106 from the stem-cell-derived islets graft indicates that dissociation kinetics can be improved. Further studies using alternative binders of similar classes with improved binding potential are warranted.
Source: EJNMMI Research - Category: Radiology Source Type: research
More News: Chemistry | Diabetes | Diabetes Type 1 | Endocrinology | Insulin | Pancreas | PET Scan | Radiology | Stem Cell Therapy | Stem Cells | Study | Transplants